Simulations Plus, Inc. (SLP) Upgraded to “Buy” by BidaskClub
BidaskClub upgraded shares of Simulations Plus, Inc. (NASDAQ:SLP) from a hold rating to a buy rating in a report released on Thursday morning.
Separately, Zacks Investment Research cut Simulations Plus from a buy rating to a hold rating in a research report on Wednesday, September 20th.
Shares of Simulations Plus (SLP) traded down 1.50% during trading on Thursday, hitting $16.45. The stock had a trading volume of 75,577 shares. The firm has a market cap of $283.68 million, a P/E ratio of 52.22 and a beta of -0.70. The firm has a 50 day moving average price of $15.04 and a 200 day moving average price of $13.14. Simulations Plus has a 12-month low of $8.10 and a 12-month high of $17.40.
Simulations Plus (NASDAQ:SLP) last posted its earnings results on Friday, July 14th. The technology company reported $0.13 EPS for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.02. Simulations Plus had a return on equity of 23.21% and a net margin of 24.86%. The firm had revenue of $6.75 million for the quarter, compared to analysts’ expectations of $6.48 million. On average, equities analysts expect that Simulations Plus will post $0.32 earnings per share for the current fiscal year.
In other Simulations Plus news, major shareholder Walter S. Woltosz sold 18,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 27th. The shares were sold at an average price of $15.45, for a total value of $285,825.00. Following the transaction, the insider now directly owns 5,647,916 shares of the company’s stock, valued at approximately $87,260,302.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 36.93% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company raised its position in shares of Simulations Plus by 13.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock valued at $110,000 after buying an additional 1,085 shares during the period. OxFORD Asset Management LLP purchased a new stake in shares of Simulations Plus during the 2nd quarter valued at approximately $126,000. Rhumbline Advisers purchased a new stake in shares of Simulations Plus during the 2nd quarter valued at approximately $126,000. New York State Common Retirement Fund purchased a new stake in shares of Simulations Plus during the 2nd quarter valued at approximately $143,000. Finally, KCG Holdings Inc. purchased a new stake in shares of Simulations Plus during the 1st quarter valued at approximately $152,000. 32.01% of the stock is currently owned by hedge funds and other institutional investors.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.